ANTH Forecast and Technical Stock Analysis
Sell candidate since 2019-12-02 Loss -12.24% PDF
Anthera Pharmaceuticals fell by -6.41% in the last day ( Wednesday, 11th Dec 2019 ) from $0.04 to $0.04 and has now fallen 3 days in a row. During the day the stock fluctuated 14.71% from a day low at $0.03 to a day high of $0.04. The price has been going up and down for this period, and there has been a 1.05% gain for the last 2 weeks. Volume has increased in the last day by 51 422 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 71 683 shares bought and sold for approximately $2 616.43.
- 30 day high of the ANTH stock price was $0.05 and low was $0.03.
- 90 day high was $0.08 and low was $0.03.
- 52 week high for Anthera Pharmaceuticals - $0.10 and low - $0.02.
Anthera Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.37% during the next 3 months and, with 90% probability hold a price between $0.02 and $0.04 at the end of this period.
There are few to none technical positive signals at the moment. Anthera Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.04 and $0.04. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday December 05, 2019, which indicates further falls until a new bottom pivot has been found. Anthera Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
RSI14 is 46 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Anthera Pharmaceuticals finds support from accumulated volume at $0.04.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 14.71%. For the last week, the stock has had a daily average volatility of 24.31%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
24.31 %Average volatility
Very Low Low Medium High Very High
Anthera Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate candidate.
|ANTH $0.04 ($0.00 -6.41%)|
ANTH is down $0.00 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for ANTH based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ANTH analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!